Done prescriber convicted in stimulant distribution conspiracy
Oct 4, 2026 edition · GC-2026-0169 · Published 2026-10-04 · Version 2 · Final
An October 2 jury verdict convicted Done prescriber Jonathan Decker of a controlled-substance conspiracy and six distribution counts. DOJ describes more than two million stimulant pills, prescribing without adequate examination and ignored patient-safety warnings. The statutory maximum is not an imposed sentence.
What happened
DOJ announced on October 2 that a federal jury convicted Jonathan Decker of conspiracy to distribute controlled substances and six counts of distribution. The case concerned more than two million stimulant pills prescribed through the Done telemedicine platform. The release describes Decker prescribing methamphetamine and amphetamines without examining patients, including people whose substance-use and significant mental-health conditions were worsened by the prescribed drugs. It reports that he received more than $1 million for prescriptions. These are findings described in the account of a jury conviction, a different procedural posture from an indictment alleging unproven conduct.
The announcement places Decker’s conduct within a larger Done prosecution while distinguishing his own prescribing from the platform-wide distribution totals. It describes continued prescribing after warnings about adverse psychiatric effects, pharmacy refusals to fill prescriptions and referral bonuses for recruiting other prescribers. The account highlights the interaction of clinical assessment, warning escalation and financial incentives in a digital prescribing model. At the announcement, sentencing had not been set. DOJ states a maximum exposure of 140 years, but explains that a judge will determine the sentence using the applicable guidelines and statutory factors; that maximum is not a prison term already ordered.
Scope and timing
- Authority status
- Final
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks, Health-tech
- Jurisdiction
- Federal
Why it matters
The action identifies a control failure relevant to provider, payer or vendor oversight. Its procedural status must be kept separate from any allegation.
Recommended action
Review telehealth controlled-substance prescribing, clinical independence, order-volume outliers and platform compensation controls. Do not substitute technology approval for valid prescribing authority.
Case details
- agencies
- U.S. Department of Justice
- entities
- Jonathan Decker, Done platform
- action Type
- Criminal resolution
- event Date
- 2026-10-02
- alleged Conduct
- Conspiracy and unlawful stimulant distribution through a telehealth prescribing platform.
- resolution
- Jury conviction announced; sentence has not been imposed.
Operational lessons
- Review telehealth controlled-substance prescribing, clinical independence, order-volume outliers and platform compensation controls. Do not substitute technology approval for valid prescribing authority.
Sources
- Doctor convicted of conspiring to distribute over two million stimulant pillsOfficial · DOJ · 2026-10-02 · Source review 2026-10-04
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Enforcement Briefing report →